Patient Preferences for Nonvitamin K Antagonist Oral Anticoagulants in Stroke Prevention: A Multicountry Discrete Choice Experiment

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Attribute</td><td class="align_center">Level 1</td><td class="align_center">Level 2</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Frequency of administration</td><td class="align_center">Once daily</td><td class="align_center">Twice daily</td></tr><tr><td class="align_left">Size of tablet/capsule</td><td class="align_center">6–9 mm tablet</td><td class="align_center">20 mm capsule</td></tr><tr><td class="align_left">Meal-related intake</td><td class="align_center">Intake with food required</td><td class="align_center">Intake independent of food</td></tr><tr><td class="align_left">Distance to treating physician</td><td class="align_center">1 km</td><td class="align_center">10 km</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Attributes and levels used in the discrete choice experiment.</div>

Cardiology Research and Practice

tab1

Table 1

Table 1: Patient Preferences for Nonvitamin K Antagonist Oral Anticoagulants in Stroke Prevention: A Multicountry Discrete Choice Experiment 